|
SGCE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83945999999713E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.243540E-03 |
| Normal-vs-Stage2 |
1.366350E-01 |
| Normal-vs-Stage3 |
1.319640E-01 |
| Normal-vs-Stage4 |
4.981200E-01 |
| Stage1-vs-Stage2 |
9.290400E-01 |
| Stage1-vs-Stage3 |
7.112600E-01 |
| Stage1-vs-Stage4 |
6.031400E-01 |
| Stage2-vs-Stage3 |
7.216600E-01 |
| Stage2-vs-Stage4 |
6.092800E-01 |
| Stage3-vs-Stage4 |
7.696600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356650E-04 |
| Normal-vs-AfricanAmerican |
5.081200E-03 |
| Normal-vs-Asian |
2.455400E-01 |
| Caucasian-vs-AfricanAmerican |
6.392000E-01 |
| Caucasian-vs-Asian |
6.229200E-01 |
| AfricanAmerican-vs-Asian |
7.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.476500E-03 |
| Normal-vs-Female |
3.96830000004567E-06 |
| Male-vs-Female |
5.681200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.524000E-01 |
| Normal-vs-Extreme_Weight |
1.526290E-02 |
| Normal-vs-Obese |
2.557200E-03 |
| Normal-vs-Extreme_Obese |
5.738800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.024000E-01 |
| Normal_Weight-vs-Obese |
1.044030E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.039400E-01 |
| Extreme_Weight-vs-Obese |
5.290600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.451400E-01 |
| Obese-vs-Extreme_Obese |
5.105600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.804500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.6216599999952E-05 |
| Normal-vs-Age(61-80Yrs) |
3.187800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.999820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.956600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.519500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.946000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.462380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.117200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.851600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76940000429227E-08 |
| Normal-VS-Type2 PRCC |
2.921000E-01 |
| Normal-VS-KIRP CIMP |
1.010450E-02 |
| Normal-VS-Unclassified PRCC |
6.782700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.50520000025334E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.925200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.092400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.663800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.298760E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.034000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.188600E-01 |
| Normal-vs-N1 |
2.071900E-02 |
| Normal-vs-N2 |
3.269800E-01 |
| N0-vs-N1 |
3.676100E-02 |
| N0-vs-N2 |
2.421600E-01 |
| N1-vs-N2 |
9.111200E-01 |
|
|
